Cargando…
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa
Autores principales: | Seltzer, Janyla A., Okeke, Chidubem A.V., Perry, Jessica D., Shipman, William D., Okoye, Ginette A., Byrd, Angel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205672/ https://www.ncbi.nlm.nih.gov/pubmed/32389715 http://dx.doi.org/10.1016/j.jaad.2020.05.012 |
Ejemplares similares
-
Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020) -
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020) -
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020) -
What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa
por: Okeke, Chidubem A. V., et al.
Publicado: (2022)